Technology and Data

Nicole Pezzino, PharmD, BCACP, BC-ADM, CDCES, discusses the opportunities incorporating pharmacy technology can create for pharmacies and their businesses.

Don Roosan, PharmD, PhD, discusses the ethical implications of AI in pharmacy, focusing on patient safety, transparency, and the importance of human connection in care.

Don Roosan, PharmD, PhD, discusses the changing technology, challenging conventional boundaries of pharmaceutical practice through telepharmacy and artificial intelligence.

With disruptive PBMs rising in the marketplace amid constant calls for lowering drug prices, companies such as WriteWise are positioned to revolutionize the way patients access their pharmacy benefits.

Lissette Logan, PharmD, and Danielle Weaver, PharmD, discuss their use of the PRISM platform for providing contraceptive and family-planning services.

Researchers conduct a proof-of-concept study exploring the feasibility of health information technology interoperability between a medical office and independent pharmacies.

In hospitalized patients with obesity, researchers conduct a study detailing how electronic clinical support helps participants optimize their treatment regimens.

To better understand its potential role in the pharmacy profession, researchers explore artificial intelligence and the ways pharmacists are aware of its growing implementation.

In an exploration of provider reporting and pharmacovigilance, researchers assessed community pharmacists’ knowledge, attitudes, and practices regarding adverse drug reactions.

Gaining insight from Walgreens’ senior director of immunizations, Samantha Picking, PharmD, discusses her company’s innovative approaches to boosting vaccination rates.

Colleges of pharmacy are retooling curricula and faculty skill sets to ensure students are prepared to use the technology of the next decade.

Polypharmacy and potentially inappropriate medications are cited as concerns in older adults who require long-term care, especially for those with comorbidities or at multiple institutions.

Researchers conducted a scoping review to evaluate conversational AI agents and their use in pharmacy education.

David Swenson, RPh, Founder and CEO of ShortStop Rx, joined Drug Topics to discuss the CCT Rx Shortage Solutions technology and how it’s helping combat drug shortages in the US.

Insulin delivery technology company Sequel Med Tech announced its future partnership with Abbott’s glucose-ketone sensor, which is currently under development.

NBC News Medical Analyst Vin Gupta, MD, joins Drug Topics at NCPDP 2025 to discuss the technological evolution of the pharmacy profession.

The NCPDP’s Executive Vice President of Innovation & Standards joins Drug Topics to discuss how AI has been making itself known within the pharmacy profession.

Larry King, PharmD, joins Drug Topics at NCPDP 2025 to discuss pharmacy interoperability, changes in its regulations, and how technology will fall into place within the data infrastructure.

In part 3 of our interview with Vin Gupta, MD, he discusses pharmacists’ role in remote patient care amid a growing technological infrastructure.

In the second part of our interview with Miranda Rochol, she discusses challenges regarding digital prescription solutions and the financial burdens these solutions are designed for pharmacists to overcome.

In her expertise as a leader with the American Pharmacists Association, Brigid Groves, PharmD, MS, provides insights into her work with geographical information systems and maps.

Vin Gupta, MD, discusses trends and perspectives in patient data privacy as well as what a “smart pharmacy” may look like in the near future.

Stanley V. Campbell, Jr., CEO of EagleForce Associates, Inc., and Yi Deng, PhD, Senior Vice President of Engineering at EagleForce, discuss the basics of AI and how it’s assisting with compliance.

Stanley V. Campbell, Jr., CEO of EagleForce Associates, Inc., and Yi Deng, PhD, Senior Vice President of Engineering at EagleForce, explore real-world examples of AI giving time back to pharmacists.

Stanley V. Campbell, Jr., CEO of EagleForce Associates, Inc., and Yi Deng, PhD, Senior Vice President of Engineering at EagleForce, discuss how AI is being used to benefit patients.